Security key
76155X118
Revolution Medicines, Inc. - *W EXP 12/17/202 (RVMDW)
CUSIP: 76155X118
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / *W EXP 12/17/202
- Total 13F shares
- 10,046,740
- Share change
- +1,348,510
- Total reported value
- $17,825,175
- Price per share
- $1.79
- Number of holders
- 21
- Value change
- +$2,736,012
- Number of buys
- 8
- Number of sells
- 7
Report period
Q1 2026
Institutions
21
Top holders
10
RVMDW full security history
Previous quarter: Q4 2025
Revolution Medicines, Inc. SEC filings
Revolution Medicines, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 76155X118
Recent filing periods:
Top shareholders of RVMDW - Revolution Medicines, Inc. - *W EXP 12/17/202 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Farallon Capital Partners, L.P. |
13D/G
|
Dapice Joshua J. |
7.5%
|
14,596,149
|
$1,499,170,464 | +$137,025,822 | 31 Dec 2025 | |
| FMR LLC |
13F
13D/G
|
Company |
5%
from 13D/G
|
8,587,981
|
$684,032,699 | — | 31 Dec 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
13D/G
|
Company |
4.9%
from 13D/G
|
12,303,502
|
$980,035,989 | — | 31 Dec 2025 | |
| BAKER BROS. ADVISORS LP |
13D/G
13F
|
Company |
4.9%
|
9,455,357
|
$971,159,717 | +$9,283,443 | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
4.5%
from 13D/G
|
8,926,656
|
$711,008,150 | — | 31 Dec 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13D/G
13F
|
Company |
3.6%
|
6,987,639
|
$717,700,402 | -$336,077,288 | 31 Dec 2025 | |
| Alan B. Sandler |
3/4/5
|
Chief Development Officer |
0.03%
|
53,000
|
$4,221,450 | — | 20 Mar 2026 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.4%
|
16,719,886
|
$1,331,738,920 | — | 31 Dec 2025 | |
| Nextech Invest, Ltd. |
13F
|
Company |
3.8%
|
7,601,087
|
$605,426,580 | — | 31 Dec 2025 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
3.3%
|
6,644,403
|
$529,226,699 | — | 31 Dec 2025 | |
| Bellevue Group AG |
13F
|
Company |
2.5%
|
5,005,719
|
$398,705,518 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.1%
|
4,109,290
|
$327,304,949 | — | 31 Dec 2025 | |
| BVF INC/IL |
13F
|
Company |
1.7%
|
3,356,782
|
$267,367,686 | — | 31 Dec 2025 | |
| Alphabet Inc. |
13F
|
Company |
1.7%
|
3,345,102
|
$266,437,374 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.6%
|
3,161,963
|
$251,911,578 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
1.5%
|
3,087,937
|
$245,954,181 | — | 31 Dec 2025 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.5%
|
2,894,613
|
$230,555,925 | — | 31 Dec 2025 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
1.4%
|
2,845,013
|
$226,605,319 | — | 31 Dec 2025 | |
| GENERAL ATLANTIC, L.P. |
13F
|
Company |
1.4%
|
2,812,928
|
$224,049,715 | — | 31 Dec 2025 | |
| Casdin Capital, LLC |
13F
|
Company |
1.3%
|
2,577,333
|
$205,284,573 | — | 31 Dec 2025 | |
| Woodline Partners LP |
13F
|
Company |
1.3%
|
2,500,895
|
$199,196,287 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.3%
|
2,491,583
|
$198,454,586 | — | 31 Dec 2025 | |
| NORGES BANK |
13F
|
Company |
1.2%
|
2,455,347
|
$195,568,389 | — | 31 Dec 2025 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
1.1%
|
2,200,376
|
$175,260,000 | — | 31 Dec 2025 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
1.1%
|
2,170,000
|
$172,840,500 | — | 31 Dec 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1%
|
2,056,857
|
$163,828,755 | — | 31 Dec 2025 | |
| Polar Capital Holdings Plc |
13F
|
Company |
1%
|
2,013,791
|
$160,398,453 | — | 31 Dec 2025 | |
| Logos Global Management LP |
13F
|
Company |
1%
|
2,000,000
|
$159,300,000 | — | 31 Dec 2025 | |
| Holocene Advisors, LP |
13F
|
Company |
0.96%
|
1,907,948
|
$151,968,058 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.84%
|
1,683,729
|
$134,109,015 | — | 31 Dec 2025 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.67%
|
1,335,270
|
$106,354,256 | — | 31 Dec 2025 | |
| Siren, L.L.C. |
13F
|
Individual |
0.67%
|
1,335,075
|
$106,338,724 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.65%
|
1,302,361
|
$103,733,053 | — | 31 Dec 2025 | |
| Caligan Partners LP |
13F
|
Company |
0.64%
|
1,283,900
|
$102,262,635 | — | 31 Dec 2025 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.6%
|
1,200,000
|
$95,580,000 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.58%
|
1,161,646
|
$92,525,396 | — | 31 Dec 2025 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
0.57%
|
1,141,195
|
$90,896,182 | — | 31 Dec 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.57%
|
1,137,121
|
$90,654,301 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.55%
|
1,090,416
|
$86,851,634 | — | 31 Dec 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.53%
|
1,060,171
|
$84,442,601 | — | 31 Dec 2025 | |
| S.c.a. Candriam |
13F
|
Individual |
0.52%
|
1,030,992
|
$82,122,009 | — | 31 Dec 2025 | |
| Hood River Capital Management LLC |
13F
|
Company |
0.47%
|
945,585
|
$75,315,845 | — | 31 Dec 2025 | |
| a16z Capital Management, L.L.C. |
13F
|
Company |
0.46%
|
921,099
|
$73,365,535 | — | 31 Dec 2025 | |
| AIHC Capital Management Ltd |
13F
|
Company |
0.45%
|
900,392
|
$71,716,223 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.44%
|
879,845
|
$70,079,654 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.43%
|
850,323
|
$67,728,228 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.4%
|
800,118
|
$63,729,399 | — | 31 Dec 2025 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
0.4%
|
797,455
|
$63,517,291 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.33%
|
651,732
|
$51,910,527 | — | 31 Dec 2025 | |
| First Turn Management, LLC |
13F
|
Company |
0.32%
|
638,385
|
$50,847,365 | — | 31 Dec 2025 |
Institutional Holders of Revolution Medicines, Inc. - *W EXP 12/17/202 (RVMDW) as of Q1 2026
As of 31 Mar 2026,
Revolution Medicines, Inc. - *W EXP 12/17/202 (RVMDW) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,046,740 shares.
The largest 10 holders included
LMR Partners LLP, D. E. Shaw & Co., Inc., Sculptor Capital LP, ARISTEIA CAPITAL, L.L.C., PRICE T ROWE ASSOCIATES INC /MD/, Caption Management, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Lunate Capital Ltd, PERCEPTIVE ADVISORS LLC, and Bleichroeder LP.
This page lists
21
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
22
Q1 2026 holders
21
Holder diff
-1
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.